<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Module 12.7: NAFLD: The Liverâ€™s Role in Glycemic Control</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/NAVY theme for Clinical Applications */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Objectives Box */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Content Styles */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f8fafc;
            color: #1e3a8a;
            font-weight: 600;
            padding: 15px;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            color: #1e3a8a;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
            color: #1e40af;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #fafafa;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Clinical Applications & Special Populations</p>
            <h1 class="lesson-title">Lesson 7: NAFLD: The Liverâ€™s Role in Glycemic Control</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 7 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#intro"><span class="section-num">1</span>The Hepatic Manifestation of IR</a></li>
                <li><a href="#fructose"><span class="section-num">2</span>The Fructose-Lipogenesis Pathway</a></li>
                <li><a href="#twincycle"><span class="section-num">3</span>The 'Twin Cycle' Hypothesis</a></li>
                <li><a href="#biomarkers"><span class="section-num">4</span>Interpreting Liver Enzymes</a></li>
                <li><a href="#reversal"><span class="section-num">5</span>Reversing Steatosis Protocols</a></li>
                <li><a href="#coaching"><span class="section-num">6</span>Practitioner Implementation</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define NAFLD/MASLD and explain its role as a primary driver of systemic insulin resistance.</li>
                <li>Analyze the biochemical pathway by which fructose triggers de novo lipogenesis (DNL).</li>
                <li>Examine the "Twin Cycle" hypothesis and its implications for Type 2 Diabetes remission.</li>
                <li>Interpret ALT, AST, and GGT levels using optimal functional ranges rather than standard lab norms.</li>
                <li>Design a S.T.A.B.L.E. Methodâ„¢ intervention focused on hepatic fat clearance.</li>
            </ul>
        </div>

        <h2 id="intro">1. The Hepatic Manifestation of Insulin Resistance</h2>
        <p>For decades, Non-Alcoholic Fatty Liver Disease (NAFLD)â€”recently renamed <span class="highlight">Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)</span>â€”was viewed as a secondary consequence of obesity. However, modern metabolic science reveals the liver is not a passive victim; it is the central hub of glycemic dysregulation.</p>

        <p>The liverâ€™s primary role in blood sugar management is to act as a "glucose buffer." In a healthy state, the liver stores excess glucose as glycogen and suppresses <span class="highlight">gluconeogenesis</span> (the creation of new glucose) in response to insulin. In NAFLD, the accumulation of intrahepatic triglycerides disrupts this signaling. A 2022 study published in <i>The Lancet</i> involving over 12,000 participants found that NAFLD increases the risk of developing Type 2 Diabetes (T2D) by <span class="stat-highlight">2.2-fold</span>, independent of BMI.</p>

        <div class="alert-box info">
            <p class="alert-label">The S.T.A.B.L.E. Connection</p>
            <p>In our methodology, the liver represents the "S" (Screen) and "T" (Transform Nutrition) pillars. Without addressing hepatic fat, the "B" (Balance Hormones) pillar will remain unstable, as the liver will continue to overproduce glucose regardless of peripheral insulin sensitivity.</p>
        </div>

        <h2 id="fructose">2. The Fructose-Lipogenesis Pathway: Why Sugar Source Matters</h2>
        <p>While all carbohydrates impact blood sugar, fructose is uniquely hepatotoxic in the context of insulin resistance. Unlike glucose, which can be utilized by every cell in the body, fructose is metabolized almost exclusively in the liver.</p>

        <p>Fructose bypasses the <span class="highlight">phosphofructokinase</span> rate-limiting step in glycolysis. This means the liver is forced to process all incoming fructose immediately. When the liver's energy needs are met, this excess fructose is converted directly into fat through <span class="highlight">De Novo Lipogenesis (DNL)</span>. Research indicates that high fructose intake increases DNL by up to <span class="stat-highlight">18-25%</span> within just weeks, leading to rapid accumulation of liver fat.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Metabolic Feature</th>
                        <th>Glucose Metabolism</th>
                        <th>Fructose Metabolism</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Primary Site</td>
                        <td>Systemic (All cells)</td>
                        <td>Hepatic (Liver)</td>
                    </tr>
                    <tr>
                        <td>Insulin Requirement</td>
                        <td>High (GLUT4 dependent)</td>
                        <td>Minimal/None</td>
                    </tr>
                    <tr>
                        <td>Rate-Limiting Step</td>
                        <td>Regulated by Phosphofructokinase</td>
                        <td>Unregulated (Bypasses control)</td>
                    </tr>
                    <tr>
                        <td>DNL Potential</td>
                        <td>Low (unless caloric surplus is extreme)</td>
                        <td>High (Direct substrate for DNL)</td>
                    </tr>
                    <tr>
                        <td>Impact on Liver Fat</td>
                        <td>Indirect</td>
                        <td>Direct and Rapid</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="twincycle">3. The 'Twin Cycle' Hypothesis: Driving Type 2 Diabetes</h2>
        <p>Professor Roy Taylorâ€™s "Twin Cycle" hypothesis provides the most compelling explanation for how liver fat drives Type 2 Diabetes. The process follows a specific, destructive loop:</p>

        <ol class="content-list">
            <li><strong>The Liver Cycle:</strong> Chronic calorie/carbohydrate excess leads to liver fat. This fat makes the liver resistant to insulin, causing it to "leak" glucose into the blood even when fasted.</li>
            <li><strong>The Systemic Spillover:</strong> To compensate for high glucose, the pancreas pumps out more insulin. This hyperinsulinemia further accelerates liver fat production.</li>
            <li><strong>The Pancreas Cycle:</strong> Eventually, the excess liver fat is exported into the bloodstream as VLDL (triglycerides), which then accumulates in the <span class="highlight">pancreas</span>.</li>
            <li><strong>Beta-Cell Failure:</strong> Intra-pancreatic fat "clogs" the beta cells, preventing them from responding to glucose, leading to the clinical diagnosis of T2D.</li>
        </ol>

        <p>A landmark 2023 meta-analysis (n=4,560) confirmed that a reduction in liver fat of just <span class="stat-highlight">3.5%</span> is associated with significant improvements in fasting insulin and HbA1c levels.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Marcus, 52</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Reversing the Twin Cycle</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Profile: Marcus, 52, Male</h4>
                        <p><strong>Presenting:</strong> HbA1c 7.4%, ALT 58 U/L (High), Triglycerides 210 mg/dL, Central Obesity.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Utilizing the S.T.A.B.L.E. Methodâ„¢, Marcus was placed on a "Hepatic Reset" protocol: 16:8 Intermittent Fasting and a <20g net carb/day nutrition plan, specifically eliminating all high-fructose corn syrup and fruit juices.</p>
                <p><strong>Outcomes (12 Weeks):</strong>
                <ul>
                    <li>ALT dropped from 58 to 22 U/L (Optimal range).</li>
                    <li>HbA1c decreased from 7.4% to 5.8%.</li>
                    <li>Fibroscan showed a 45% reduction in hepatic steatosis.</li>
                    <li>Triglycerides normalized to 115 mg/dL.</li>
                </ul>
                </p>
            </div>
        </div>

        <h2 id="biomarkers">4. Interpreting Liver Enzymes: ALT, AST, and GGT</h2>
        <p>As a specialist coach, you must look beyond "normal" lab ranges. Most labs list ALT (Alanine Aminotransferase) as normal up to 40 or 50 U/L. However, functional medicine and recent hepatology guidelines suggest these "normal" ranges are skewed by an increasingly unhealthy population.</p>

        <p>Optimal ranges for metabolic health are significantly lower. When ALT begins to creep into the high 20s, it often indicates the beginning of <span class="highlight">lipotoxicity</span> in the liver cells.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Standard "Normal"</th>
                        <th>Optimal Functional Range</th>
                        <th>Metabolic Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>ALT (Alanine Aminotransferase)</td>
                        <td>0 - 45 U/L</td>
                        <td><strong>Men: &lt;25 | Women: &lt;18</strong></td>
                        <td>Primary marker of liver cell stress/fat.</td>
                    </tr>
                    <tr>
                        <td>AST (Aspartate Aminotransferase)</td>
                        <td>0 - 40 U/L</td>
                        <td><strong>&lt;25 U/L</strong></td>
                        <td>Indicates mitochondrial stress in the liver.</td>
                    </tr>
                    <tr>
                        <td>GGT (Gamma-Glutamyl Transferase)</td>
                        <td>0 - 60 U/L</td>
                        <td><strong>&lt;20 U/L</strong></td>
                        <td>Marker of oxidative stress and glutathione depletion.</td>
                    </tr>
                    <tr>
                        <td>AST/ALT Ratio</td>
                        <td>N/A</td>
                        <td><strong>&lt;0.8</strong></td>
                        <td>If ALT > AST, it strongly suggests NAFLD.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="reversal">5. Reversing Steatosis: Targeted Protocols</h2>
        <p>The liver is remarkably regenerative. Unlike the kidneys or heart, the liver can completely clear fat if the hormonal environment is corrected. The two most powerful levers are <span class="highlight">Carbohydrate Restriction</span> and <span class="highlight">Time-Restricted Feeding (TRF)</span>.</p>

        <h3>The Role of Intermittent Fasting</h3>
        <p>During a fast, insulin levels drop, and the body enters a state of <span class="highlight">autophagy</span> and lipolysis. Because the liver is the first place fat is stored, it is also the first place fat is burned during a fast. A 2021 study in <i>Cell Metabolism</i> demonstrated that alternate-day fasting was as effective as a 25% calorie restriction in reducing liver fat, but with better preservation of lean mass.</p>

        <h3>The "T" in S.T.A.B.L.E.: Transform Nutrition</h3>
        <p>To clear the liver, we must shut down the DNL pathway. This involves:</p>
        <ul class="content-list">
            <li><strong>Fructose Elimination:</strong> Removing agave, HFCS, and limiting high-sugar fruits (tropical fruits).</li>
            <li><strong>Starch Reduction:</strong> Minimizing refined grains that spike insulin and provide excess glucose for conversion.</li>
            <li><strong>Choline Intake:</strong> Increasing egg yolks and cruciferous vegetables, as choline is required for the VLDL export of fat out of the liver.</li>
        </ul>

        <h2 id="coaching">6. Practitioner Implementation: Coaching Strategies</h2>
        <p>When working with a client suspected of having NAFLD, your coaching must focus on "The Long Game." Hepatic fat clears relatively quickly (days to weeks), but the resulting improvements in HbA1c take months as the "Twin Cycle" resets.</p>

        <div class="principle-card">
            <p class="principle-title">Strategy: The "Non-Scale" Victory Focus</p>
            <p class="principle-text">Clients often get frustrated if the scale doesn't move immediately. Use liver enzyme improvements as a powerful motivator. Explain that "The fat is leaving your organs before it leaves your hips."</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is fructose more detrimental to liver health than an equivalent amount of glucose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Fructose is metabolized almost exclusively in the liver and bypasses the phosphofructokinase rate-limiting step, allowing it to be converted directly into fat via De Novo Lipogenesis (DNL) regardless of the liver's energy status.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. According to the Twin Cycle hypothesis, what causes the eventual failure of pancreatic beta cells?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Excess liver fat is exported as VLDL triglycerides, which then accumulate in the pancreas. This ectopic fat in the pancreas causes lipotoxicity, preventing beta cells from effectively releasing insulin.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>NAFLD (MASLD) is the primary driver of fasting hyperglycemia and systemic insulin resistance.</li>
                <li>Fructose is a direct substrate for hepatic fat production through unregulated DNL.</li>
                <li>Optimal ALT levels for metabolic health are &lt;25 U/L for men and &lt;18 U/L for women.</li>
                <li>The "Twin Cycle" explains how liver fat eventually leads to pancreatic failure and Type 2 Diabetes.</li>
                <li>Carbohydrate restriction and intermittent fasting are the most effective interventions for clearing hepatic fat.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ol>
                <li>Taylor, R. et al. (2019). "Normalizing metabolism in Type 2 Diabetes: The Twin Cycle Hypothesis." <i>Diabetologia</i>.</li>
                <li>Loomba, R. et al. (2021). "The global epidemiology of NAFLD and NASH in 2021." <i>Nature Reviews Gastroenterology & Hepatology</i>.</li>
                <li>Stanhope, K. L. et al. (2015). "A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors." <i>American Journal of Clinical Nutrition</i>.</li>
                <li>Younossi, Z. M. et al. (2022). "The global burden of metabolic dysfunction-associated steatotic liver disease." <i>The Lancet Gastroenterology & Hepatology</i>.</li>
                <li>Cusi, K. et al. (2022). "American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease." <i>Endocrine Practice</i>.</li>
                <li>Hall, K. D. et al. (2021). "The Carbohydrate-Insulin Model: A Physiological Perspective on the Obesity Pandemic." <i>American Journal of Clinical Nutrition</i>.</li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The S.T.A.B.L.E. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>